Clinical Trial: Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer

Sponsor and Collaborators

Contact
Alan Brisendine, CCRP
843-792-9007

Principal Investigator
Melanie B. Thomas, MD
Medical University of South Carolina

ClinicalTrials.gov Identifier 
NCT00881751